TITLE

Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas

AUTHOR(S)
Noh, Kyucheol; Kim, Kyung-Ok; Patel, Neel R.; Staples, J. Robert; Minematsu, Hiroshi; Nair, Kumar; Lee, Francis Young-In
PUB. DATE
April 2011
SOURCE
Journal of Bone & Joint Surgery, American Volume;4/20/2011, Vol. 93-A Issue 8, p723
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: A subset of patients with aggressive osteosarcomas responds poorly to conventional cytotoxic chemotherapy. Recent evidence from studies involving the liver, skin, stomach, and colon suggests that carcinogenesis is associated with inflammation. Mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2 (ERK1/2) has diverse roles in cancer and inflammation. The hypothesis of the present study is that targeted ERK1/2 inhibition will demonstrate anti-cancer effects in osteosarcoma both in vitro and in vivo. Methods: The therapeutic effect of PD98059, a MAPK/ERK pathway inhibitor, was examined with respect to cell death, survival, and anti-apoptotic protein expression by means of flow cytometry and immunoblotting in vitro. Additionally, we transplanted green fluorescent protein and luciferase-tagged 143B osteosarcoma cells into the proximal part of the tibia of nude mice. Mice were randomly assigned to treatment with doxorubicin, PD98059, or both. Vehicle-treated mice served as ôontrbls. Treatment outcome was assessed by measuring bioluminescence and by monitoring survival. Results: In vitro, ERK1/2 blockage increased the expression of pro-apoptotic proteins and increased cell death in 143B osteosarcoma cells. Doxorubicin treatment increased the expression of Bcl-2, an anti-apoptotic protein, but this upregulation was blocked by combined treatment with PD98059, suggesting a role for ERK1/2 in conferring drug resistance. In osteosarcoma-bearing mice, targeting ERK1/2 with PD98059 resulted in prolonged survival in comparison with vehicle- treated control mice (median survival time, sixty-seven days compared with seventy-four days; p = 0.0272; survival ratio = 0.9122; 95% confidence interval = 0.4354 to 1.389). Standalone doxorubicin treatment yielded similar animal morbidity (median survival time, sixty-seven days compared with seventy-six days; p = 0.0170; survival ratio = 0.8882; 95% confidence interval = 0.4181 to 1.358). Combined PD98059 and doxorubicin treatment further prolonged survival (median survival time, sixty-seven days compared with eighty-two days; p = 0.0023; survival ratio = 0.8232; 95% confidence interval = 0.3606 to 1.286). Conclusions: Inhibiting ERK1/2 signaling resulted in osteosarcoma cell death by upregulating pro-apoptotic genes and inhibiting the Bcl-2-mediated resistance to doxorubicin. In osteosarcoma-bearing mice, ERK1/2 targeting alone or in combination with doxorubicin prolonged survival as compared with untreated mice. Clinical Relevance: Our study highlights the anti-cancer effect of the inflammatory kinase inhibitor PD98059 on osteosarcoma cells by inducing cell death and by inhibiting a potential drug-resistance mechanism. Taken together, these results suggest that ERK signaling blockade (targeted therapy) may be considered as a new targeted adjuvant therapy for osteosarcoma.
ACCESSION #
60439342

 

Related Articles

  • The roles of MAPKs in rabbit nucleus pulposus cell apoptosis induced by high osmolality. Z.-H. DONG; D.-C. WANG; T.-T. LIU; F.-H. LI; R.-L LIU; J.-W. WEI; C.-L ZHOU // European Review for Medical & Pharmacological Sciences;Oct2014, Vol. 18 Issue 19, p2835 

    BACKGROUND: Earlier work has suggested that the p38 MAPK, JNK1/2 and ERK1/2 signal pathway existed in nucleus pulposus cells and the cell growth, differentiation and apoptosis were regulated by them. Because osmotic fluctuations are inevitable in the physicochemical environment of intervertebral...

  • The Role of the P2X7 Receptor in Infectious Diseases. Miller, Catherine M.; Boulter, Nicola R.; Fuller, Stephen J.; Zakrzewski, Alana M.; Lees, Michael P.; Saunders, Bernadette M.; Wiley, James S.; Smith, Nicholas C. // PLoS Pathogens;Nov2011, Vol. 7 Issue 11, Special section p1 

    ATP is an extracellular signal for the immune system, particularly during an inflammatory response. It is sensed by the P2X7 receptor, the expression of which is upregulated by pro-inflammatory cytokines. Activation of the P2X7 receptor opens a cation-specific channel that alters the ionic...

  • Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer. Mountzios, Giannis; Kostopoulos, Ioannis; Kotoula, Vassiliki; Sfakianaki, Ioanna; Fountzilas, Elena; Markou, Konstantinos; Karasmanis, Ilias; Leva, Sofia; Angouridakis, Nikolaos; Vlachtsis, Konstantinos; Nikolaou, Angelos; Konstantinidis, Ioannis; Fountzilas, George // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Introduction: Prognosis of patients with operable laryngeal cancer is highly variable and therefore potent prognostic biomarkers are warranted. The insulin-like growth factor receptor (IGFR) signaling pathway plays a critical role in laryngeal carcinogenesis and progression. Patients and...

  • The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. Moens, Ugo; Kostenko, Sergiy; Sveinbjørnsson, Baldur // Genes;Jun2013, Vol. 4 Issue 2, p101 

    Mitogen-activated protein kinase (MAPK) pathways are implicated in several cellular processes including proliferation, differentiation, apoptosis, cell survival, cell motility, metabolism, stress response and inflammation. MAPK pathways transmit and convert a plethora of extracellular signals by...

  • RACK1 antagonizes TNF-α-induced cell death by promoting p38 activation. Wang, Qingyang; Zhou, Silei; Wang, Jing-Yang; Cao, Junxia; Zhang, Xueying; Wang, Jing; Han, Kun; Cheng, Qianqian; Qiu, Guihua; Zhao, Yawei; Li, Xinying; Qiao, Chunxia; Li, Yan; Hou, Chunmei; Zhang, Jiyan // Scientific Reports;9/18/2015, p14298 

    p38 mitogen-activated protein kinase (MAPK) activity has been reported to either promote or suppress cell death, which depends on cell type and stimulus. Our previous report indicates that p38 exerts a protective role in tumor necrosis factor (TNF)-α-induced cell death in L929 fibroblastoma...

  • The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. Zeze Fu; Biyong Deng; Yuxin Liao; Liancheng Shan; Fei Yin; Zhuoying Wang; Hui Zeng; Dongqing Zuo; Yingqi Hua; Zhengdong Cai; Fu, Zeze; Deng, Biyong; Liao, Yuxin; Shan, Liancheng; Yin, Fei; Wang, Zhuoying; Zeng, Hui; Zuo, Dongqing; Hua, Yingqi; Cai, Zhengdong // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Osteosarcoma is the most frequent primary malignant bone tumor, notorious for its lung metastasis. Shikonin, an effective constituent extracted from Chinese medicinal herb, was demonstrated to induce necroptosis in some cancers.Methods: MTT assay was...

  • Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1β induced rat fibroblast-like synoviocytes. Saravanan, S.; Hairul Islam, V.; Thirugnanasambantham, K.; Pazhanivel, N.; Raghuraman, N.; Gabriel Paulraj, M.; Ignacimuthu, S. // Inflammation Research;Jun2014, Vol. 63 Issue 6, p451 

    Objective and design: Rheumatoid arthritis is a chronic inflammatory and autoimmune disease that leads to aggressive joint cartilage and bone destruction. Swertiamarin is a secoiridoid glycoside found in Enicostema axillare (Lam) A. Raynal, a medicinal plant used in the Indian system of...

  • MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. GANG HAN; YAN WANG; WENZHI BI; JINPENG JIA; WEI WANG // Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 3, p679 

    MicroRNA-124 (miR-124) has been demonstrated to be downregulated in numerous human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma remains unclear. Thus, the aim of the present study was to explore the effects of miR-124 in...

  • Cytotoxicity of Environmentally Relevant Concentrations of Aluminum in Murine Thymocytes and Lymphocytes. Kamalov, Jamal; Carpenter, David O.; Birman, Irina // Journal of Toxicology;2011, p1 

    The effects of low concentrations of aluminumchloride on thymocytes and lymphocytes acutely dissociated from young mice were studied using flow cytometry with a DNA-binding dye. We demonstrate a rapid and dose-dependent injury in murine thymocytes and lymphocytes resulting from exposure to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics